Trial intelligence / Profile preview

Pravastatin for hypercholesterolemia in HIV patients receiving protease inhibitors

ACTRN12605000663651Phase 4Completed

Sponsor
University of New South Wales
Start
Jul 2002
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hypercholesterolemia and dyslipidemia comparing Pravastatin with Placebo (2 arms). Primary endpoint: Between-group difference in time-weighted change from baseline in fasting serum total cholesterol. Started Jul 2002; status: completed.

02

Drugs

pravastatin
03

Conditions

hypercholesterolemiadyslipidemia

Beyond the preview

Go deeper on ACTRN12605000663651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12605000663651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call